Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Dura Biotech

Dura Biotech
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
3 INVESTORS
Description

Developer of technologies designed to improve the functionality and durability of bioprosthetic valves. The company's technologies include the transcatheter valve replacement/repair systems and a pre-operative planning software of transcatheter valve intervention, enabling clinicians to avail durable and elegant services to treat complex diseases and ultimately improve patients' lives.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Primary Office
  • 20A Pasco Drive
  • East Windsor, CT 06088
  • United States

+1 (860) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Dura Biotech’s full profile, request a free trial.

Dura Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Aug-2018 Completed Generating Revenue
3. Grant 15-Jul-2016 00000 Completed Generating Revenue
2. Grant 30-Dec-2014 $2M Completed Generating Revenue
1. Accelerator/Incubator 01-Apr-2013 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Dura Biotech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
The University of Connecticut's Technology Incubation Program Accelerator/Incubator 000 0000 000000 0

Dura Biotech Executive Team (4)

Name Title Board
Seat
Contact
Info
Isa Risk Chief Executive Officer
Thuy Pham Co-Founder & Chief Technology Officer
Wei Sun Co-Founder & Scientific Advisor

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »